Welcome to LookChem.com Sign In|Join Free

CAS

  • or

404010-35-1

Post Buying Request

404010-35-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

404010-35-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 404010-35-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,4,0,1 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 404010-35:
(8*4)+(7*0)+(6*4)+(5*0)+(4*1)+(3*0)+(2*3)+(1*5)=71
71 % 10 = 1
So 404010-35-1 is a valid CAS Registry Number.

404010-35-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(3-amino-5-tert-butyl-2-methoxy-phenyl)-methanesulfonamide

1.2 Other means of identification

Product number -
Other names N-(3-amino-5-tert-butyl-2-methoxyphenyl)methanesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:404010-35-1 SDS

404010-35-1Relevant articles and documents

Novel chromene diarylurea compounds, and preparation method and application thereof

-

, (2017/08/28)

The invention relates to compounds represented by the general formula I, or isomers, pharmaceutical salts and solvates thereof; the invention also relates to a composition containing the compounds represented by the general formula I, or the isomers, the

KINASE INHIBITORS

-

, (2014/10/16)

There are provided compounds of formula I, wherein R1A to R1E, R2 to R5, L and X1 to X3 have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: the family of p38 mitogen-activated protein kinase enzymes; Syk kinase; and members of the Src family of tyrosine kinases) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.

7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases

-

Page/Page column 51, (2011/11/12)

The present invention provides compounds according to general formula (I) which are proposed for the treatment of respiratory complaints, particularly asthma and COPD.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 404010-35-1